Literature DB >> 10616026

Evidence for the participation of anti-ribosomal P antibodies in lupus nephritis.

M Reichlin1, M Wolfson-Reichlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10616026     DOI： 10.1002/1529-0131(199912)42:12<2728::AID-ANR34>3.0.CO;2-M

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  10 in total

1.  Technical and clinical evaluation of anti-ribosomal P protein immunoassays.

Authors:  M Mahler; K Kessenbrock; J Raats; M J Fritzler
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

Review 2.  Anti-ribosomal P antibodies and lupus nephritis.

Authors:  Shunsei Hirohata
Journal:  Clin Exp Nephrol       Date:  2011-06-07       Impact factor: 2.801

3.  Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins.

Authors:  M Mahler; K Kessenbrock; J Raats; R Williams; M J Fritzler; M Blüthner
Journal:  J Mol Med (Berl)       Date:  2003-03-14       Impact factor: 4.599

4.  Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus.

Authors:  J L J Lin; V Dubljevic; M J Fritzler; Ban-Hock Toh
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

5.  International multicenter evaluation of autoantibodies to ribosomal P proteins.

Authors:  Michael Mahler; Kai Kessenbrock; Magdalena Szmyrka; Yoshinari Takasaki; Ignacio Garcia-De La Torre; Yehuda Shoenfeld; Falk Hiepe; Chen Shun-le; Carlos A von Mühlen; Henning Locht; Peter Höpfl; Allan Wiik; Westley Reeves; Marvin J Fritzler
Journal:  Clin Vaccine Immunol       Date:  2006-01

6.  Anti-ribosomal antibodies from lupus patients bind DNA.

Authors:  L Caponi; D Chimenti; F Pratesi; P Migliorini
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

7.  Diverse humoral autoimmunity to the ribosomal P proteins in systemic lupus erythematosus and hepatitis C virus infection.

Authors:  K Kessenbrock; M J Fritzler; M Groves; P Eissfeller; C A von Mühlen; P Höpfl; M Mahler
Journal:  J Mol Med (Berl)       Date:  2007-08-01       Impact factor: 4.599

8.  Anti-ribosomal phosphoprotein autoantibody triggers interleukin-10 overproduction via phosphatidylinositol 3-kinase-dependent signalling pathways in lipopolysaccharide-activated macrophages.

Authors:  Tai-Ping Lee; Shr-Jeng Jim Leu; Jason C Huang; Ying-Chyi Song; Ren-Shiang Jhou; Shye-Jye Tang; Kuang-Hui Sun
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

9.  Clinical aspects and risk factors of lupus nephritis: a retrospective study of 156 adult patients.

Authors:  Fang Yuan; Fenghua Wei; Junjie Wang; Yanwu You
Journal:  J Int Med Res       Date:  2019-09-12       Impact factor: 1.671

Review 10.  Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?

Authors:  Emese Kiss; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.